M&A Deal Summary

Revvity Acquires Caliper Life Sciences

On November 7, 2011, Revvity acquired life science company Caliper Life Sciences for 600M USD

Acquisition Highlights
  • This is Revvity’s 4th transaction in the Life Science sector.
  • This is Revvity’s 3rd largest (disclosed) transaction.
  • This is Revvity’s 16th transaction in the United States.
  • This is Revvity’s 6th transaction in Massachusetts.

M&A Deal Summary

Date 2011-11-07
Target Caliper Life Sciences
Sector Life Science
Buyer(s) Revvity
Deal Type Add-on Acquisition
Deal Value 600M USD
Advisor(s) Perella Weinberg Partners (Financial)

Target

Caliper Life Sciences

Hopkinton, Massachusetts, United States
Caliper Life Sciences, Inc. is a provider of imaging and detection solutions for life sciences research, diagnostics and environmental markets.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Revvity

Waltham, Massachusetts, United States

Category Company
Founded 1937
Sector Medical Products
Employees11,000
Revenue 2.8B USD (2023)
DESCRIPTION

Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity was formerly known as PerkinElmer. The Company was formed in 1937 and is based in Waltham, Massachusetts.


DEAL STATS #
Overall 22 of 36
Sector (Life Science) 4 of 8
Type (Add-on Acquisition) 20 of 34
State (Massachusetts) 6 of 8
Country (United States) 16 of 19
Year (2011) 6 of 6
Size (of disclosed) 3 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-16 Labtronics

Guelph, Ontario, Canada

Labtronics Inc., an Ontario, Canada-based engages in providing procedures-based Electronic Laboratory Notebook (ELN) solutions for laboratories performing routine analysis in multiple industries.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-11-12 Shanghai Haoyuan Biotech

Shanghai, China

Shanghai Haoyuan Biotech Co., Ltd. is an infectious disease diagnostics company. Shanghai Haoyuan Biotech supplies molecular infectious disease screening technologies for blood bank and clinical laboratory settings.

Buy -